ALXO

SEC source: 0001415889-25-001963 · form4-01232025_110146.xml · derivative · entry 1

Sandler Alan B. · CIK 0001835966 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

SEC source: 0001415889-25-001959 · form4-01232025_110159.xml · derivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 478,000

Underlying: Common Stock · 478,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

SEC source: 0001415889-25-001120 · form4-01082025_090144.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,902

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-25-000123 · form4-01022025_090125.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,714

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-25-000132 · form4-01022025_090133.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,123

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-028247 · form4-12042024_091224.xml · nonDerivative · entry 1

Hemrajani Rekha · CIK 0001771213 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.515 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001415889-24-028245 · form4-12042024_091224.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2031-12-01

F1 · derivative.exercise_date: Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025.

SEC source: 0001415889-24-028239 · form4-12042024_091258.xml · derivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-12-01

F1 · derivative.exercise_date: Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025.

SEC source: 0001415889-24-027181 · form4-11192024_091142.xml · derivative · entry 1

Sandler Alan B. · CIK 0001835966 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-11-17

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 18, 2025 and 1/48th of the shares vest monthly thereafter.

SEC source: 0001415889-24-021480 · form4-08162024_090823.xml · nonDerivative · entry 1

Randolph Sophia · CIK 0001817127 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,711

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

SEC source: 0001415889-24-021474 · form4-08162024_090846.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 591,510

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

SEC source: 0001415889-24-021482 · form4-08162024_090836.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,549

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

SEC source: 0001415889-24-021476 · form4-08162024_090807.xml · nonDerivative · entry 1

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,516

F1 · kind: The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

SEC source: 0001415889-24-021471 · form4-08162024_090831.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,429

F1 · kind: The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

SEC source: 0001415889-24-020932 · form4-08072024_090845.xml · derivative · entry 1

Sandler Alan B. · CIK 0001835966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2034-08-04

F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on September 5, 2024.

SEC source: 0001415889-24-019546 · form4-07152024_080721.xml · derivative · entry 3

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,433

Underlying: Common Stock · 20,000 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable.

SEC source: 0001415889-24-019546 · form4-07152024_080721.xml · nonDerivative · entry 2

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 593,447

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.90 to 7.905, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-019546 · form4-07152024_080721.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 613,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-019429 · form4-07092024_080737.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,113

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-019224 · form4-07032024_090700.xml · nonDerivative · entry 1

Randolph Sophia · CIK 0001817127 · Director · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,076

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-019221 · form4-07032024_090724.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 593,447

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-019228 · form4-07032024_090722.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,936

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024.

SEC source: 0001415889-24-018919 · form4-07022024_080741.xml · nonDerivative · entry 1

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,277

F1 · kind: The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

F2 · balance_after: Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024.

SEC source: 0001415889-24-016955 · form4-06142024_080638.xml · derivative · entry 1

Hemrajani Rekha · CIK 0001771213 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,200

Underlying: Common Stock · 20,200 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders.

SEC source: 0001415889-24-016952 · form4-06142024_080642.xml · derivative · entry 1

Garland J. Scott · CIK 0001533228 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,200

Underlying: Common Stock · 20,200 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders.

SEC source: 0001415889-24-016949 · form4-06142024_080636.xml · derivative · entry 1

GOODMAN COREY S · CIK 0001278411 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,200

Underlying: Common Stock · 20,200 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders.

SEC source: 0001415889-24-017054 · form4-06172024_110650.xml · nonDerivative · entry 1

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,348

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001415889-24-017899 · form4a-06242024_010651.xml · nonDerivative · entry 1

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,348

F1 · kind: For purposes of the short-swing profit recovery provisions of Section 16(b) of the Securities Exchange Act of 1934, the acquisition of shares reported herein may be deemed to be matchable to the extent of 1,893 shares with the reporting person's sale of 1,893 shares of Issuer common stock to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units on December 29, 2023. The reporting person has agreed to pay to the Issuer $11,959.88, which represents the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001415889-24-015737 · form4-06062024_080618.xml · derivative · entry 3

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,433

Underlying: Common Stock · 20,000 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable.

SEC source: 0001415889-24-015737 · form4-06062024_080618.xml · nonDerivative · entry 2

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 604,205

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-015737 · form4-06062024_080618.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 624,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-013237 · form4-05152024_080510.xml · nonDerivative · entry 2

Randolph Sophia · CIK 0001817127 · Director · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 330,349

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $16.94, inclusive.

SEC source: 0001415889-24-013237 · form4-05152024_080510.xml · nonDerivative · entry 1

Randolph Sophia · CIK 0001817127 · Director · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332,146

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.465 to $16.4602, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

SEC source: 0001415889-24-012637 · form4-05082024_090502.xml · derivative · entry 3

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,433

Underlying: Common Stock · 20,000 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable.

SEC source: 0001415889-24-012637 · form4-05082024_090502.xml · nonDerivative · entry 2

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 604,205

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $16.3942, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-012637 · form4-05082024_090502.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 624,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-011128 · form4-04182024_080417.xml · derivative · entry 3

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,433

Underlying: Common Stock · 25,846 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable.

SEC source: 0001415889-24-011128 · form4-04182024_080417.xml · nonDerivative · entry 2

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 604,205

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-011128 · form4-04182024_080417.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 654,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-010443 · form4-04052024_090425.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 628,359

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023.

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.86 to $11.275, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-24-008260 · form4-03182024_080318.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,620

SEC source: 0001415889-24-004227 · form4-02162024_110240.xml · derivative · entry 2

Randolph Sophia · CIK 0001817127 · Director · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.

SEC source: 0001415889-24-004227 · form4-02162024_110240.xml · nonDerivative · entry 1

Randolph Sophia · CIK 0001817127 · Director · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,349

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.

SEC source: 0001415889-24-004218 · form4-02162024_110225.xml · derivative · entry 2

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.

SEC source: 0001415889-24-004218 · form4-02162024_110225.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · Director · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648,359

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.

SEC source: 0001415889-24-004233 · form4-02162024_110202.xml · derivative · entry 2

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.

SEC source: 0001415889-24-004233 · form4-02162024_110202.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,591

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.

SEC source: 0001415889-24-004231 · form4-02162024_110247.xml · derivative · entry 2

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.

SEC source: 0001415889-24-004231 · form4-02162024_110247.xml · nonDerivative · entry 1

GARCIA PETER S · CIK 0001188956 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,348

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.

SEC source: 0001415889-24-004210 · form4-02162024_110246.xml · derivative · entry 2

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.